National Cancer Center Singapore
Singapore, Singapore
5 recruiting
Showing 1–7 of 7 trials
Recruiting
Phase 1Phase 2
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Metastatic Solid TumorsLocally Advanced Solid Tumors
Turning Point Therapeutics, Inc.500 enrolled165 locationsNCT03093116
Recruiting
Phase 3
A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.
Refractory Follicular LymphomaFollicular LymphomaRelapsed/Refractory Follicular Lymphoma
Epizyme, Inc.612 enrolled229 locationsNCT04224493
Recruiting
Phase 2
Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC
Colorectal, CancerColorectal CarcinomaHepatocellular Carcinoma+2 more
National Cancer Centre, Singapore60 enrolled1 locationNCT04912765
Recruiting
Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLC
Non-small Cell Lung CancerALK-Positive Lung Cancer
National Cancer Centre, Singapore50 enrolled5 locationsNCT04087473
Recruiting
Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients
Prostate CancerNasopharyngeal CancerOther Cancer
National Cancer Centre, Singapore5,000 enrolled1 locationNCT04340024
Recruiting
Phase 2
Phase II Study of PRL3-ZUMAB in Advanced Solid Tumors
Gastric CancerHepatocellular CarcinomaAdvanced Solid Tumor
National Cancer Centre, Singapore30 enrolled1 locationNCT04118114
Recruiting
Phase 1
PIPAC for Peritoneal Metastases
Peritoneal Metastases
National Cancer Centre, Singapore25 enrolled1 locationNCT04956068